Although tumor loss of IFN-γ signaling has been defined as a major mechanism of resistance to anti-CTLA-4 (Fig. 1h)9 and anti-PD-110–14, little effort has been devoted to overcome this ICB resistance. Here, CTLA4 is linked to neoplasm.